Tony explains this positioning strategy allows them to target different demographics with the same ingredients, similar to how they might position Setria differently for immune health versus skin health applications
Roughly, 43.8 percent of participants had subcapsular cataracts, 24.3 percent had nuclear cataracts and 28.6 percent had cortical cataracts, and 27.6 percent with mixed type cataracts had high blood pressure
Results vary depending on your dose, lifestyle, and how long you stay on the medication
Although tirzepatide carries a lower intrinsic risk of hypoglycemia compared to insulin or sulfonylureas when used as monotherapy, patients taking tirzepatide with concomitant insulin or insulin secretagogues may experience hypoglycemic episodes that could be more difficult to detect if beta blockers are also prescribed
As such, these agents are generally contraindicated in patients with a personal or family history of MTC and in patients with multiple endocrine neoplasia syndrome type 2 (MEN2)
